Apellis shares surge over 142% in pre-market trading, Biogen to acquire pharmaceutical company Apellis for $5.6 billion
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The company will acquire Apellis at a price of $41 per share, more than double Apellis's closing price on Monday. Through this deal, Biogen will gain ownership of two approved drugs.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
ECB Governing Council Member Kocher: June Meeting to Decide on Rate Hike or Hold Steady
Cointime•2026/05/13 12:52
Delphi Digital: MicroStrategy's bitcoin accumulation has entered a more costly phase
BlockBeats•2026/05/13 11:40
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$79,639.22
-1.08%
Ethereum
ETH
$2,256.44
-0.66%
Tether USDt
USDT
$0.9996
-0.00%
BNB
BNB
$669.47
+2.16%
XRP
XRP
$1.42
-0.46%
USDC
USDC
$0.9997
-0.01%
Solana
SOL
$91.12
-3.72%
TRON
TRX
$0.3500
+0.64%
Dogecoin
DOGE
$0.1111
+1.98%
Hyperliquid
HYPE
$38.98
-3.48%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now